Mkts

Greenwich LifeSciences, Inc.

NASDAQ: GLSI
$14.94-0.34 (-2.23%)
As of Nov 13, 4:00 PM ET

Key statistics

Day range
14.5615.87
52-week range
7.7834.10
Today
Open15.87
Previous close14.94
Volume84.1K
Valuation
Market cap219.29M
P/E ratio—
EPS (TTM)-1.53
Income & risk
Dividend / yield—
Beta1.64
Avg volume137.9K
Discussion

GLSI News

Stories mentioning GLSI from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue
Cost of Goods Sold
Gross Profit0.000.000.000.000.000.000.000.00
Operating Expenses
Research & Development5,2088,2663,2673,4162,2718,6852,2922,308
Sales General & Admin
Total Operating Expenses5,7269,1763,7343,7692,7699,7102,7292,661
Operating Income (Loss)(5,726)(8,458)(4,175)(4,046)(2,769)(9,710)(2,729)(2,661)
Interest Income69.0022.0023.0021.0024.0044.0060.0055.00
Interest Expense
Other Expense
Pretax Income
Tax Provision
Net Income (Loss)(5,657)(9,153)(3,711)(3,749)(2,745)(9,665)(2,669)(2,607)
Earnings Per Share (Basic)(0.39)(0.68)(0.27)(0.28)(0.21)(0.74)(0.20)(0.20)
Earnings Per Share (Diluted)(0.39)(0.68)(0.27)(0.28)(0.21)(0.74)(0.20)(0.20)
Weighted Average Shares Outstanding (Basic)14,56513,53513,64113,37113,17213,01513,14212,907
Weighted Average Shares Outstanding (Diluted)14,56513,53513,64113,37113,17213,01513,14212,907

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About GLSI

Greenwich LifeSciences, Inc. (NASDAQ: GLSI) is a stock listed on the Nasdaq Stock Market under the ticker symbol GLSI. It last traded at $14.94 (Nov 13, 2026, 4:00 PM ET), down 2.2% on the day. That gives Greenwich LifeSciences a market capitalisation of $219.3M.

Over the past 52 weeks GLSI has traded between $7.78 and $34.10.

For the quarter ended Mar 31, 2026 it reported a net loss of $5.7M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026—-$5.7M
Dec 31, 2025—-$9.2M
Sep 30, 2025—-$3.7M
Jun 30, 2025—-$3.7M

From Greenwich LifeSciences’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…